Fragment-based development of triazole-substituted O-galactosyl aldoximes with fragment-induced affinity and selectivity for galectin-3
- PMID: 19763301
- DOI: 10.1039/b909091f
Fragment-based development of triazole-substituted O-galactosyl aldoximes with fragment-induced affinity and selectivity for galectin-3
Abstract
A fragment-based development of 3C-triazol-1-yl-O-galactopyranosyl aldoximes led to the discovery of highly selective and high affinity (K(d) down to 11 microm) small monosaccharide based inhibitors of galectin-3. Galectin-7, 8 N-terminal CRD, and 9 N-terminal CRD bound the inhibitors only weakly. The galectin-3 selectivity was hypothesized to stem from interaction of the aldoxime moiety with a site not present in the other galectins.
Similar articles
-
1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.Bioorg Med Chem. 2010 Jul 15;18(14):5367-78. doi: 10.1016/j.bmc.2010.05.040. Epub 2010 May 20. Bioorg Med Chem. 2010. PMID: 20538469
-
Synthesis of O-galactosyl aldoximes as potent LacNAc-mimetic galectin-3 inhibitors.Bioorg Med Chem Lett. 2005 May 2;15(9):2343-5. doi: 10.1016/j.bmcl.2005.02.079. Bioorg Med Chem Lett. 2005. PMID: 15837322
-
Synthesis of galactose-mimicking 1H-(1,2,3-triazol-1-yl)-mannosides as selective galectin-3 and 9N inhibitors.Carbohydr Res. 2007 Sep 3;342(12-13):1869-75. doi: 10.1016/j.carres.2007.03.012. Epub 2007 Mar 14. Carbohydr Res. 2007. PMID: 17407769
-
Human galectin-3 selective and high affinity inhibitors. Present state and future perspectives.Curr Med Chem. 2013;20(24):2979-90. doi: 10.2174/09298673113209990163. Curr Med Chem. 2013. PMID: 23834183 Review.
-
Galectin-3 inhibitors: a patent review (2008-present).Expert Opin Ther Pat. 2014 Oct;24(10):1053-65. doi: 10.1517/13543776.2014.947961. Epub 2014 Aug 9. Expert Opin Ther Pat. 2014. PMID: 25109359 Review.
Cited by
-
Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists.Mol Divers. 2011 May;15(2):347-60. doi: 10.1007/s11030-010-9285-y. Epub 2010 Nov 14. Mol Divers. 2011. PMID: 21076980 Free PMC article.
-
Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.Mass Spectrom Rev. 2015 May-Jun;34(3):268-422. doi: 10.1002/mas.21411. Epub 2014 May 26. Mass Spectrom Rev. 2015. PMID: 24863367 Free PMC article. Review.
-
Synthetic glycoconjugates inhibitors of tumor-related galectin-3: an update.Glycoconj J. 2016 Dec;33(6):853-876. doi: 10.1007/s10719-016-9721-z. Epub 2016 Aug 15. Glycoconj J. 2016. PMID: 27526114 Review.
-
Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies.RSC Adv. 2020 Aug 13;10(50):29873-29884. doi: 10.1039/d0ra04795c. eCollection 2020 Aug 10. RSC Adv. 2020. PMID: 35518264 Free PMC article.
-
Protein flexibility and conformational entropy in ligand design targeting the carbohydrate recognition domain of galectin-3.J Am Chem Soc. 2010 Oct 20;132(41):14577-89. doi: 10.1021/ja105852y. J Am Chem Soc. 2010. PMID: 20873837 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources